Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial(†)

Por Advani, R. H., Hoppe, R. T., Baer, D., Mason, J., Warnke, R., Allen, J., Daadi, S., Rosenberg, S. A., Horning, S. J.
Publicado em 2013

Comparison of Conventional Prognostic Indices in Patients Older than 60 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 97...

Por Advani, R.H., Chen, H., Habermann, T.M, Morrison, V.A., Weller, E.A., Fisher, R.I., Peterson, B. A., Gascoyne, R.D., Horning, S.J.
Publicado em 2010

A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era

Por Hosein, P.J., Maragulia, J.C., Salzberg, M.P., Press, O.W., Habermann, T.M., Vose, J.M., Bast, M., Advani, R.H., Tibshirani, R., Evens, A.M., Islam, N., Leonard, J.P., Martin, P., Zelenetz, A.D., Lossos, I.S.
Publicado em 2014

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for Advanced Hodgkin Lymphoma in the Modern Era

Por Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Crump, M., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T., Horning, S. J., Advani, R. H.
Publicado no Br J Haematol (2015)